Abbott Stock: Bear Trap Over, With Richer Return Prospects (NYSE:ABT)
· seekingalpha.com
Abbott (ABT) buy thesis: diversified growth, EXAS-driven cancer diagnostics upside, attractive valuation & dividend yield, bull-case LTPT $139—read now.
I am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge, I hope to provide other investors with a contrasting view ...